{"filing":{"accession_number":"0001493152-26-024584","cik":"0000727346","ticker":"GBCS","company_name":"SELECTIS HEALTH, INC.","form":"8-K","filing_date":"2026-05-20","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/727346/000149315226024584/form8-k.htm"},"events":[{"id":1277,"run_id":1101,"accession_number":"0001493152-26-024584","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Adam Desmond resigned effective May 14, 2026 from all positions including CEO and CFO, with a Separation Agreement filed as Exhibit 10.1. While the filing also discloses the appointment of Krystal Eckhart as Interim CEO and CFO on May 15, 2026, the principal disclosed event centers on the departure of the CEO/CFO. The departure of a chief executive officer is material to investors assessing company leadership and continuity.","company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","filing_date":"2026-05-20","items":null}],"classifications":[{"id":706,"accession_number":"0001493152-26-024584","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"Adam Desmond resigned effective May 14, 2026 from all positions including CEO and CFO, with a Separation Agreement filed as Exhibit 10.1. While the filing also discloses the appointment of Krystal Eckhart as Interim CEO and CFO on May 15, 2026, the principal disclosed event centers on the departure of the CEO/CFO. The departure of a chief executive officer is material to investors assessing company leadership and continuity.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-21T02:53:14.923954+00:00","company_name":"SELECTIS HEALTH, INC.","ticker":"GBCS","filing_date":"2026-05-20"}]}